Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

[Göppingen 1999 vaccination program in the 5th and 6th grade].

Oettinger B, Gröber U, Ernst E.

Gesundheitswesen. 2000 Oct;62(10):505-10. German.

PMID:
11103561
4.

Serosurvey of measles, mumps and rubella antibodies in Saudi children.

Al-Mazrou YY, Khalil MK, Tischer A, Al-Jeffri MH, Al-Ghamdi YS, Bakhsh MM, Mishkas AA, Elgizouli SA.

Saudi Med J. 2005 Oct;26(10):1551-4.

PMID:
16228054
5.

Sero-response to measles-mumps-rubella vaccine campaign in Saudi Arabia.

Al-Mazrou YY, Khalil MK, Tumsah S, Al-Ghamdi YS, Al-Jeffri MH, Tischer AB, Mishkhas AA, Eissa M.

Saudi Med J. 2002 Jun;23(6):680-3.

PMID:
12070547
6.

[Surveillance of measles in Germany].

Tischer A, Siedler A, Rasch G.

Gesundheitswesen. 2001 Nov;63(11):703-9. German.

PMID:
11713702
7.

Why do parents hesitate to vaccinate their children against measles, mumps and rubella?

Alfredsson R, Svensson E, Trollfors B, Borres MP.

Acta Paediatr. 2004 Sep;93(9):1232-7.

PMID:
15384890
8.

Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium.

Theeten H, Vandermeulen C, Roelants M, Hoppenbrouwers K, Depoorter AM, Van Damme P.

Acta Paediatr. 2009 Aug;98(8):1307-12. doi: 10.1111/j.1651-2227.2009.01331.x. Epub 2009 May 7.

PMID:
19432835
9.
10.

[35-year measles, mumps, rubella vaccination assessment in France].

Reinert P, Soubeyrand B, Gauchoux R.

Arch Pediatr. 2003 Nov;10(11):948-54. French.

PMID:
14613687
11.

[Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].

Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.

Praxis (Bern 1994). 1999 Jun 10;88(24):1069-77. German.

PMID:
10420798
12.

Progress toward implementation of a second-dose measles immunization requirement for all schoolchildren in the United States.

Kolasa MS, Klemperer-Johnson S, Papania MJ.

J Infect Dis. 2004 May 1;189 Suppl 1:S98-103.

PMID:
15106097
13.

Risk factors for undervaccination against measles in a large sample of preschool children from rural Bavaria.

Zucs AP, Crispin A, Eckl E, Weitkunat R, Schlipköter U.

Infection. 2004 Jun;32(3):127-33.

PMID:
15188070
14.

Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.

Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D.

Pediatrics. 2006 Jul;118(1):e139-50.

PMID:
16818529
15.

[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].

Zäch K, Nicoara C, Germann D, Matter L.

Schweiz Med Wochenschr. 1998 Apr 25;128(17):649-57. German.

PMID:
9622837
17.

Outbreak of measles in primary school students with high first dose MMR vaccination coverage.

Ong G, Rasidah N, Wan S, Cutter J.

Singapore Med J. 2007 Jul;48(7):656-61.

18.

[Measles, mumps and rubella vaccination status of school beginners in Munich].

Markuzzi A, Schlipköter U, Weitkunat R, Meyer G.

Soz Praventivmed. 1997;42(3):133-43. German.

PMID:
9334085
19.

Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren.

Roost HP, Gassner M, Grize L, Wüthrich B, Sennhauser FH, Varonier HS, Zimmermann H, Braun-Fahrländer Ch; SCARPOL-team.

Pediatr Allergy Immunol. 2004 Oct;15(5):401-7.

PMID:
15482514
20.

Achieving 95% uptake in an immunisation programme--not an impossibility.

Joyce-Cooney J, Meagher G, Quinn C, Cavanagh I.

Ir Med J. 2003 Oct;96(9):268-70.

PMID:
14753580

Supplemental Content

Support Center